Testing was performed at alere (b)(4) on retained kit lots 102459 and 101439 with the following internal serum plasma control samples: (b)(6).All test results were valid and performed as expected.Additionally, the manufacturing batch records for lots 102459 and 101439 were reviewed.These lots met the required release specifications.A review of the complaints reported as (b)(6) related to lots 102459 and 101439 showed that the complaint rate is (b)(4), respectively.The evidence available does not indicate that the product is performing outside label claims.Alere (b)(4) was unable to determine the exact root cause of the reported issue.The results obtained may possibly be related to the patient sample.The sample may have contained specific substances which may have affected the results.The available evidence suggests that these device lots are performing within labeled claims.
|